Nanohale AG (ETR:FYB) | Finanzwire

Basculer en Français

10545	Companies
222782	Keywords
151846	Articles
117860	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 06/05/2025 at 06:35, 1 year ago

Lucentis® Biosimilar FYB201/Ranivisio® Gains Approval in Brazil

Formycon AG Retinal Diseases Lucentis® Biosimilar Brazil Approval Biomm Partnership
PRESS RELEASE

published on 06/05/2025 at 06:30, 1 year ago

Lucentis® biosimilar FYB201/Ranivisio® (ranibizumab) approved in Brazil
Brazil approves Formycon AG's Lucentis biosimilar FYB201/Ranivisio, marking the beginning of Latin America rollout. Commercial partnership with Biomm established

Formycon AG Lucentis Biosimilar Brazil Approval Biomm Partnership Market Rollout
BRIEF

published on 05/27/2025 at 14:35, 1 year ago

Formycon and Fresenius Kabi Launch Otulfi™ in Canada

Canadian Market Patient Support Ustekinumab Biosimilar Chronic Autoimmune Diseases Biologic Therapies
PRESS RELEASE

published on 05/27/2025 at 14:30, 1 year ago

Formycon and Fresenius Kabi announce the commercial launch of FYB202/Otulfi™, an approved ustekinumab biosimilar in Canada
Formycon and Fresenius Kabi announce commercial launch of FYB202/Otulfi ustekinumab biosimilar in Canada, expanding treatment options for chronic autoimmune diseases

Canada Formycon Fresenius Kabi Ustekinumab Biosimilar FYB202/Otulfi
BRIEF

published on 05/19/2025 at 15:05, 1 year ago

Formycon and Fresenius Kabi Achieve FDA Interchangeability Approval for FYB202/Otulfi®

FDA Approval Biosimilars Formycon Fresenius Kabi Otulfi®
PRESS RELEASE

published on 05/19/2025 at 15:00, 1 year ago

Formycon and Fresenius Kabi announce FDA Approval of Interchangeability for FYB202/Otulfi® (ustekinumab-aauz)
Formycon and Fresenius Kabi receive FDA approval for interchangeability of FYB202/Otulfi (ustekinumab-aauz) with Stelara, enhancing patient access to treatment options for inflammatory diseases in the US

FDA Approval Formycon Fresenius Kabi Biologics Interchangeability
BRIEF

published on 05/12/2025 at 06:35, 1 year ago

Formycon Achieves Key Milestones in Q1 2025 Amid Challenging Conditions

Strategic Partnerships Financial Guidance Formycon Q1 2025 Biosimilar Approvals FYB202 Launch
PRESS RELEASE

published on 05/12/2025 at 06:30, 1 year ago

Formycon reports strong operational performance and financial results for first quarter of 2025
Formycon AG reports strong operational performance and financial results for the first quarter of 2025. Market approvals, revenue growth, and strategic partnerships discussed

Financial Results Operational Performance Formycon AG Biosimilars Market Approvals
BRIEF

published on 05/07/2025 at 09:42, 1 year 1 month ago

Formycon Announces Q1 2025 Results Conference and Investor Conferences

Investor Conferences Formycon AG Management Board Financial Outlook Q1 2025 Results
PRESS RELEASE

published on 05/07/2025 at 09:37, 1 year 1 month ago

Formycon invites to conference call on the results of the first quarter of 2025 and announces participation in international investor conferences
Formycon AG to discuss Q1 2025 results in a conference call and participate in investor conferences. Details and webcast link available. Biosimilar development focus

Conference Call Investor Conferences Formycon AG Biosimilars Q1 2025 Results

Accesswire

Published on 06/10/2026 at 08:00, 3 hours 57 minutes ago

Caledonia Mining Corporation Plc: Motapa Exploration Results
Published on 06/10/2026 at 00:00, 11 hours 57 minutes ago

Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
Published on 06/09/2026 at 23:00, 12 hours 57 minutes ago

NXT Energy Solutions Inc. Announces Results of Annual Meeting of Shareholders
Published on 06/09/2026 at 22:30, 13 hours 27 minutes ago

Gamma Resources Announces Receipt of $604,500 from Warrant Exercises
Published on 06/09/2026 at 21:45, 14 hours 12 minutes ago

Northfield Announces Change of Corporate Name to Juno International Corporation

View all ACCESSWIRE

EQS Group

Published on 06/10/2026 at 11:25, 32 minutes ago

adesso Wins Contract with the Deutsche Bundesbank
Published on 06/10/2026 at 11:05, 52 minutes ago

BetFury Launches Fury World Cup '26 - Grand Sports Event For $600,000
Published on 06/10/2026 at 11:05, 52 minutes ago

PEPSI® GLOBAL LAUNCHES PEPSI 'HOUSE OF TREATS' A NEW AWAY FROM HOME EXPERIENTIAL BEVERAGE PLATFORM
Published on 06/10/2026 at 10:22, 1 hour 35 minutes ago

PNE AG: Narrowing of the coupon range to 7.000% to 7.500% for the new corporate bond 2026/2031
Published on 06/10/2026 at 10:10, 1 hour 47 minutes ago

LAMINAZIONE SOTTILE APPOINTS FABIO MARIA SGRAZZUTTI AS GROUP EXECUTIVE DIRECTOR

Les Echos

Published on 06/10/2026 at 07:00, 4 hours 57 minutes ago

Acceleration of Museum Studio's international expansion
Published on 06/09/2026 at 19:30, 16 hours 27 minutes ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 06/09/2026 at 18:14, 17 hours 43 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/05/2026
Published on 06/09/2026 at 15:17, 20 hours 40 minutes ago

Statement of transactions in own shares from June 1, 2026 to June 5, 2026
Published on 06/09/2026 at 10:37, 1 day 1 hour ago

Guillemot Corporation S.A. | Weekly report share buyback from June 1 to June 5 2026

View all LES ECHOS COMFI WIRE